Stabilisation Notice

25 September 2012

Clinigen Group plc - Offering of up to 33,550,000 Ordinary Shares

Stabilisation Notice

Pursuant to Core Dealing Rule 3070, Numis Securities Limited hereby notifies the London Stock Exchange that it may stabilise the offering of the Ordinary Shares of 0.1p each in Clinigen Group plc:

1. Security to be stabilised: Ordinary Shares of 0.1p each in Clinigen Group plc

2. Security Identifiers: ISIN Code GB00B89J2419

3. Stabilising Manager: Numis Securities Limited (a member firm) (Contact - James Black 020 7260 1000)

4. Stabilisation period commences: 25 September 2012 at approximately 08:00 London time

5. Stabilisation period ends: Close of business on 24 October 2012

6. Offer price: GBP 1.64 per Share

7. Associated securities being stabilised: None

8. Over allotment: Over allotment option is equivalent to 10% of the placing.

This announcement is for information purposes only and does not constitute or form part of, and should not be construed as, an offer for sale or subscription or solicitation of or invitation to make any offer to buy or subscribe for, underwrite or otherwise acquire or dispose of any securities in any jurisdiction, and neither this announcement nor any part of it shall form the basis of or be relied on in connection with or act as an inducement to enter into any contract or commitment whatsoever.

This announcement does not constitute or form part of, and should not be construed as, an offer for sale or subscription or solicitation of or invitation to make any offer to buy or subscribe for any securities in Australia, Canada, Japan, the Republic of Ireland or the Republic of South Africa or in any jurisdiction to whom or in which such offer or solicitation is unlawful.

Neither this announcement nor any copy of it may be made or transmitted into the United States of America or its territories or possessions, nor may it be made or transmitted into Australia, Canada, Japan, the Republic of Ireland, the Republic of South Africa or to any persons in any of those jurisdictions. Any failure to comply with the restriction may constitute a violation of United States of America, Australian, Canadian, Japanese, Irish or South African securities laws.

The securities referred to herein have not been and will not be registered under the US Securities Act. There will be no public offer of the securities. In particular, this announcement is not an offer for sale of, or solicitation to purchase or subscribe for, any securities in the United States of America.

Numis Securities Limited, which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting exclusively for Clinigen Group plc and no-one else in connection with the admission to trading on AIM and placing of shares in Clinigen Group plc. Numis will not regard any other person as its client in relation to the matters described in this announcement and will not be responsible to anyone other than Clinigen Group plc for providing the protections afforded to its clients, nor for providing advice in relation to the admission to trading on AIM and placing of shares in Clinigen Group plc, the contents of this announcement or any transaction, arrangement or other matter referred to herein.